Aurobindo Pharma reported INR17.53B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Cipla INR 9.55B 3B Mar/2026
Divis Laboratories Ltd INR 9.34B 440M Mar/2026
Dr.Reddys Laboratories INR 6.46B 14.43B Mar/2026
Hindustan Unilever INR 38.41B 530M Mar/2026
Sun Pharmaceuticals INR 39.54B 9.94B Mar/2026
UPL INR 35.58B 12.41B Mar/2026